SCHEMBL8109544

SCHEMBL8109544

CC(O)CC(Oc1ccc(-c2ccccc2)cc1)c1cccnc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.44
KCNA5 P22460 2/20 0.42
CYP17A1 P05093 1/20 0.42
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP1A2 P05177 1/20 0.41
GAA P10253 1/20 0.41
PKM P14618 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP19A1 P11511 1/20 0.41
ADRB1 P08588 1/20 0.40
ADRB3 P13945 1/20 0.40
KCNH2 Q12809 1/20 0.40
SLC6A9 P48067 2/20 0.40
KDM4E B2RXH2 1/20 0.40
CFTR P13569 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8552624 0.95 CYP19A1 (0.47) SMN1; SMN2KCNA5CYP17A1CYP2C9CYP2C19
SCHEMBL8133883 0.90 CYP17A1 (0.40) SMN1; SMN2KCNA5CYP17A1CYP2C9CYP2C19
SCHEMBL8550969 0.89 EPHX1 (0.46) SMN1; SMN2KCNA5ADRB1ADRB3KCNH2
SCHEMBL8552459 0.88 CYP17A1 (0.44) CYP17A1CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL7983312 0.88 SMN1; SMN2 (0.42) SMN1; SMN2KCNA5CYP17A1CYP2C9CYP2C19
SCHEMBL8553465 0.88 SMN1; SMN2 (0.42) SMN1; SMN2KCNA5CYP17A1CYP2C9CYP2C19
SCHEMBL8118264 0.87 DGAT2 (0.39) KCNA5CYP17A1CYP2C9CYP2C19CYP3A4
SCHEMBL8118689 0.87 KCNA5 (0.48) SMN1; SMN2KCNA5CYP17A1CYP2C9CYP2C19
SCHEMBL8118468 0.87 KCNA5 (0.45) KCNA5CYP17A1CYP3A4CYP19A1ADRB1
SCHEMBL8123208 0.87 MKNK1 (0.46) SMN1; SMN2CYP17A1CYP2C9CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1037889-A1 NOVEL COMPOUNDS AstraZeneca UK Limited (GB) 2000-09-27 EP disclosed
WO-1999029686-A1 NOVEL COMPOUNDS ASTRAZENECA UK LIMITED (GB) 1999-06-17 WO disclosed
EP-0865431-A2 COMPOUNDS Astra Pharmaceuticals Limited (GB) 1998-09-23 EP disclosed
WO-1997020815-A1 COMPOUNDS ASTRA PHARMACEUTICALS LTD. (GB) 1997-06-12 WO disclosed